Cellceutix tests psoriasis candidate, prepares for clinical trial
Cellceutix CEO Leo Ehrlich said the company is optimistic about the potential for Prurisol to reproduce the laboratory results showing the drug to eliminate all signs of psoriasis.
Fri Jun 14, 2013
Medical News Today
In Patients With Psoriatic Arthritis, Long-Term Apremilast Demonstrates Continued Efficacy
New data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses beyond 24 weeks.
Thu Jun 13, 2013
HeadSpace, The Modern Meditation Tool
Meditation , a practice that's been around for thousands of years and is rapidly becoming the preferred tool to reduce stress which is one of it's many benefits.
Cape Cod Times
Children born to mothers who get more vitamins from their diets develop stronger bones even years later, a new study shows.
Tue Jun 11, 2013
Celgene arthritis drug maintains efficacy at 52 weeks-study
Celgene Corp's experimental drug for psoriatic arthritis maintained its ability to significantly reduce painful symptoms through 52 weeks of treatment, according to data from a late stage study being presented this week at a medical meeting.
J&J's Stelara effective in psoriatic arthritis trial
Johnson & Johnson's Stelara produced significant improvement in signs and symptoms of psoriatic arthritis through 52 weeks of treatment in a late stage study, according to data being presented at a medical meeting in Europe.
Thu Jun 06, 2013
Kantar Health Study Shows 4 in 10 Psoriasis Patients Do Not See a Physician for Their Condition
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! NEW YORK, June 6, 2013-Four in 10 psoriasis patients-including 25 percent of moderate to severe patients-currently are not under the care of a physician for their condition, according to new research conducted by Kantar Health, a leading global healthcare ... (more)
For your traveler's health chaga to boost the immune system
Enhances the liver and fights viruses. This funky tree mushroom extract come from a fungus known as the chaga mushroom which grows on trees.
Wed Jun 05, 2013
Biocon Seeks Partner to Sell Rival Drug to J&J's Stelara: Corporate India
Biocon Ltd. , India's largest publicly traded biotechnology company, is in talks with U.S. drugmakers to co-develop and sell a psoriasis treatment that may rival Johnson & Johnson's Stelara.
Tue Jun 04, 2013
National Psoriasis Foundation awards $450,000 in research grants
Psoriasis is a chronic, noncontagious, genetic disease of the immune system that appears on the skin, most often as red, scaly patches that itch and bleed.
GlycaNova: Launch of Ganodex
GlycaNova, the Norwegian biotechnology company focused on over-the-counter and prescription products for immune system disorders, is pleased to announce the launch of Ganodex , its highly innovative, over-the-counter skin cream treatment for problems such as eczema and psoriasis.
Mon Jun 03, 2013
Summer skin tips for travelling with Psoriasis
Most people look forward to summer vacation and relaxing under the sun, but for people living with psoriasis, a chronic skin condition, this time of year can be embarrassing and uncomfortable.
Periodontal Disease Influencing Psoriasis
From time to time, we may wonder if one disease in the body may cause another disease to crop up.
Thu May 30, 2013
Could shedding extra pounds improve psoriasis?
Losing weight may ease psoriasis and improve quality of life for some overweight people with the chronic skin disease, new research from Denmark suggests.
Wed May 29, 2013
Weight Loss May Improve Psoriasis Symptoms In Overweight Patients
A low-calorie diet that leads to weight loss may be associated with improved psoriasis symptoms in overweight patients, according to a report published Online First by JAMA Dermatology, a JAMA Network publication.
Mon May 27, 2013
Unique Phototherapy Device Begins US Sales
TAMPA, Fla., May 27, 2013 - Psoria-Light, a new device that treats skin disorders using targeted deep-UV LEDs, has started domestic sales, product maker Psoria-Shield announced.